Massive expansion of regulatory T-cells following interleukin 2 treatment during a phase I-II dendritic cell-based immunotherapy of metastatic renal cancer. [electronic resource]
Producer: 20091001Description: 569-81 p. digitalISSN:- 1019-6439
- Adult
- Aged
- Antigens, CD34 -- immunology
- Antigens, Neoplasm -- immunology
- Antineoplastic Agents -- therapeutic use
- Cancer Vaccines -- immunology
- Carcinoma, Renal Cell -- immunology
- Dendritic Cells -- immunology
- Female
- Humans
- Immunophenotyping
- Immunotherapy -- methods
- Interleukin-2 -- therapeutic use
- Kidney Neoplasms -- immunology
- Male
- Middle Aged
- T-Lymphocytes, Regulatory -- drug effects
No physical items for this record
Publication Type: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.